NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe…

Overview of attention for article published in Respiratory Research, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 131 Mendeley

Summary Blogs Policy documents X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,949 followers.

NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled #asthma https://t.co/570pMUfqKJ

20 Oct 2020

Reply Repost Favourite